News Case study backs YolTech's AATD gene therapy A gene therapy for alpha-1 antitrypsin deficiency developed by China's YolTech has successfully treated a patient with a severe form of the disease.
Digital Sponsored Accelerating the content lifecycle: A 7-step guide for AI in... By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.
News World first as infant gets personalised CRISPR therapy In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation.
R&D Advancing innovation in life sciences R&D and Quality: Towar... This year’s Veeva R&D and Quality Summit saw full-house attendance at the Marriott Auditorium Hotel in Madrid.
R&D Case Study: MHRA Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Patients Sponsored Case Study: MHRA and AstraZeneca Agile, responsive regulation helps early breast cancer patients to benefit from a study to potentially improve survival outcomes.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.